Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$47.47 USD
-0.06 (-0.13%)
Updated Apr 22, 2024 11:55 AM ET
After-Market: $47.69 +0.22 (0.46%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.55 | -29.19% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.73 per share, missing the Zacks Consensus Estimate of -$0.66 per share. This reflects a negative earnings surprise of 10.61%. Look out for APLS's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.55 per share, reflecting a year-over-year increase of 64.74%.
Earnings History
Price & Consensus
Zacks News for APLS
Apellis (APLS) Q4 Earnings Miss, Revenues Meet Estimates
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services